Once‐daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation

O Selroos, S Edsbäcker, C Hultquist - Journal of Asthma, 2004 - Taylor & Francis
Background. Budesonide, a widely used inhaled corticosteroid (ICS) with a favorable
therapeutic ratio, is available via a dry powder inhaler (Pulmicort Turbuhaler®) and as a …
被引用次数：60 相关文章

Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation

O Selroos, S Edsbäcker… - The Journal of asthma …, 2004 - pubmed.ncbi.nlm.nih.gov
Background Budesonide, a widely used inhaled corticosteroid (ICS) with a favorable
therapeutic ratio, is available via a dry powder inhaler (Pulmicort Turbuhaler) and as a …

Once-daily inhaled budesonide for the treatment of asthma: clinical evidence and pharmacokinetic explanation.

O Selroos, S Edsbäcker, C Hultquist - … of the Association for the Care …, 2004 - europepmc.org
Background Budesonide, a widely used inhaled corticosteroid (ICS) with a favorable
therapeutic ratio, is available via a dry powder inhaler (Pulmicort Turbuhaler) and as a …

[引用][C] Once-daily inhaled budesonide for the treatment of asthma: Clinical evidence and pharmacokinetic explanation

O SELROOS, S EDSBÄCKER… - The Journal of …, 2004 - Informa Healthcare